Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-02-27Clinical Trial Update: Effect of Exercise on Endothelial Function and Vascular Compliance in Chronic Kidney Disease [NA]
This clinical trial evaluated whether an exercise program improves endothelial function and vascular compliance in individuals with chronic …
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on Dialysis
This completed clinical trial evaluated patient management practices and quality of life for paricalcitol capsules in treating secondary hyp…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Safety and Efficacy of the Early Introduction of Everolimus (Certican®) With Low Dose of Cyclosporine in de Novo Kidney Recipients After 1 Month of Transplantation [Phase 4]
Phase 4 trial assessing the safety and efficacy of early initiation of everolimus with low-dose cyclosporine in de novo kidney transplant re…
-
CLINICAL_TRIALS trial_result · 2014-02-19Clinical Trial Update: Study of Dietary Phosphate and Mineral Homeostasis in Early Chronic Kidney Disease [NA]
A completed clinical trial evaluated dietary phosphate and mineral homeostasis in individuals with early chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2014-02-11Clinical Trial Update: Circadian Rhythm Modulation by Dietary Phosphorus in Chronic Kidney Disease [NA]
A completed clinical trial (NCT01341678) investigated the effects of dietary phosphorus on circadian rhythm in chronic kidney disease. The s…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-02-10Clinical Trial Update: Sensitivity and Specificity of NGAL in an Emergency Room Population
A completed clinical trial evaluated the sensitivity and specificity of the NGAL biomarker for detecting acute kidney injury in an emergency…
-
CLINICAL_TRIALS trial_result · 2014-02-07Clinical Trial Update: Outlook: An Intervention to Improve Quality of Life in Serious Illness [NA]
A Duke University study evaluating an intervention to improve quality of life in seriously ill patients has completed, covering cancer, chro…
-
CLINICAL_TRIALS trial_result · 2014-02-04Clinical Trial Update: Use of Traditional Chinese Medicine (Ren Shen Yang Rong Tang) Against Microinflammation in Hemodialysis Patients: A Quasi-randomized Controlled Trial [Phase 4]
A Phase 4 quasi-randomized controlled trial evaluated the traditional Chinese medicine Ren Shen Yang Rong Tang for reducing microinflammatio…
-
CLINICAL_TRIALS research · 2014-01-29Clinical Trial Update: The Study of Immunogenicity of Quadrivalent Vaccine Against Human Papilloma Virus (HPV) Types 6, 11, 16, and 18 (HPV-6/11/16/18) in Chronic Kidney Disease (CKD) Patients
This clinical trial study assesses the immunogenicity of the quadrivalent HPV vaccine (types 6, 11, 16, and 18) in patients with chronic kid…
-
CLINICAL_TRIALS trial_result · 2014-01-28Clinical Trial Update: Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation [EARLY_Phase 1]
This early-phase trial studied light therapy to treat sleep-wake dysregulation in renal transplant recipients, with results posted in 2014.
-
CLINICAL_TRIALS withdrawal · 2014-01-27Clinical Trial Update: Fasiglifam in Type 2 Diabetic Subjects With Chronic Kidney Disease Stage 4 or 5 on Hemodialysis [Phase 3]
A Phase 3 clinical trial of fasiglifam in type 2 diabetes patients with chronic kidney disease on hemodialysis has been withdrawn.
-
FDA approval · 2014-01-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysis solution containing dextrose and electrolytes, manufactured by Fresenius Med…
-
FDA approval · 2014-01-24FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
FDA approved a supplemental application for DELFLEX, a dialysate solution, submitted by Fresenius Medical Care North America.
-
CLINICAL_TRIALS trial_result · 2014-01-23Clinical Trial Update: Aerobic Training and Arterial Stiffness in Chronic Kidney Disease (CKD) Patients [NA]
A completed clinical trial examines the effect of aerobic training on arterial stiffness in patients with chronic kidney disease, including …
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events [Phase 3]
Phase 3 trial update for cinacalcet hydrochloride (E.V.O.L.V.E. Trial) assessing its impact on cardiovascular events in secondary hyperparat…
-
CLINICAL_TRIALS trial_result · 2014-01-20Clinical Trial Update: Variability of Hemoglobin Levels After Kidney Transplantation
This clinical trial update reports on variability in hemoglobin levels observed after kidney transplantation in patients with anemia related…
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: Kidney and Liver Transplantation in People With HIV
Clinical trial update on kidney and liver transplantation in people with HIV has completed. The study evaluated transplantation outcomes in …
-
CLINICAL_TRIALS trial_result · 2014-01-17Clinical Trial Update: The Effect of Daily Tamsulosin 0.2mg Administration on Renal Function in Patients With Benign Prostatic Hyperplasia [NA]
This clinical trial update investigates the effect of daily tamsulosin 0.2 mg on renal function in patients with benign prostatic hyperplasi…
-
CLINICAL_TRIALS trial_result · 2014-01-14Clinical Trial Update: Study to Evaluate the Prospective Payment System
Amgen completed a study evaluating the Prospective Payment System related to chronic kidney disease and posted results in January 2014.
-
FDA approval · 2014-01-13FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental NDA for DELFLEX from Fresenius Medical Care North America. This action represents an update to the product's…
-
CLINICAL_TRIALS trial_result · 2014-01-10Clinical Trial Update: Efficacy of Calmmax Cream in the Management of Chronic Uremic Pruritus [NA]
This clinical trial update evaluates the efficacy of Calmmax Cream for uremic pruritus in chronic kidney disease. However, the status and tr…
-
CLINICAL_TRIALS trial_result · 2014-01-01Clinical Trial Update: Anemia Management in Chronic Kidney Disease Not on Dialysis Patients After the European Renal Best Practice (ERBP) Working Group Recommendations
The trial update reports results on anemia management in chronic kidney disease patients not on dialysis following ERBP recommendations. Res…
-
FDA approval · 2013-12-23FDA Approved: FERAHEME — Supplemental Application (AMAG Pharmaceuticals, Inc.)
FDA approved a supplemental application for FERAHEME (ferumoxytol) to modify its labeling for iron replacement therapy in adults with iron d…
-
CLINICAL_TRIALS trial_result · 2013-12-20Clinical Trial Update: Electroacupuncture for Hypertension Patients With Chronic Kidney Disease
A completed clinical trial evaluated electroacupuncture for managing hypertension in patients with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2013-12-16Clinical Trial Update: Pomegranate Supplementation on Physical Function and Cardiovascular Disease Risk in CKD Patients [NA]
A completed clinical trial evaluated the effects of pomegranate supplementation on physical function and cardiovascular disease risk in pati…